2024 Accreditation Information

Debates and Didactics in Hematology and Oncology
July 25-28, 2024; Sea Island, Georgia

Jointly provided by Partners for Advancing Clinical Education (PACE) and Bio Ascend LLC.

Target Audience

This activity is intended for oncologists, hematologists, pathologists, clinical scientists, nurse practitioners, physician assistants, nurses, and pharmacists charged with the care of patients with cancer.

Learning Objectives

  • Examine the results and implications of clinical trials that are examining current and emerging therapeutic regimens for patients with solid tumors, including thoracic, breast, head and neck, gynecologic, CNS, gastrointestinal, and genitourinary cancers
  • Assess the safety and efficacy of currently approved and emerging treatments for patients with hematologic malignancies, including patients with lymphoma, leukemia, and multiple myeloma
  • Discuss optimal approaches for integrating novel agents into the treatment armamentarium to maximize the outcomes of patients with hematologic and solid tumor malignancies
  • Evaluate strategies to increase patient and HCP participation in clinical trials in order to address current unmet needs faced by patients with cancer

Disclosures

PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculty
Conflicts of Interest
Sagar Lonial, MD, FACP
Consultant/Advisor/Speaker: Amgen, BMS, Celgene, GSK, Janssen, Karyopharm, Merck, Novartis
Suresh Ramalingam, MD, FASCO
Has no relevant financial relationships
Cletus Arciero, MD, FACS
Has no relevant financial relationships
Reshma Jagsi, MD, DPhil
Has no relevant financial relationships
Mylin Torres, MD
Researcher: Pfizer
Consultant/Advisor/Speaker: Onohealth, Onclive
Kevin Kalinsky, MD, MS

Consultant/Advisor/Speaker: Genentech/Roche, Immunomedics, Seattle Genetics, AstraZeneca, Daiichi Sankyo, Puma Biotechnology, Mersana, Menarini Silicon Biosystems, Myovant Sciences, Takeda, Merck
Demetria Smith-Graziani, MD, MPH
Researcher: BMS
Ruth Sacks, MD
Has no relevant financial relationships
Jade Jones, MD
Has no relevant financial relationships
Jane Lowe Meisel, MD
Researcher: AstraZeneca, Pfizer, Seagen, Olema, Sermonix Consultant/Advisor/Speaker: Clovis, Genentech, GSK, Novartis, Puma, Seagen, GE, Sermonix, Olema, AstraZeneca, Pfizer
Nabil Saba, MD, FACP
Consultant/Advisor/Speaker: Eisai Medical, Exelixis, Merck, EMD Serono, Pfizer, CUE, BionTech, GSK, TOSK, Seagen, Flamingo, Infinity , Inovio, Aveo, Medscape, BMS, Astex, Imugene, Coherus, Fulgent, Taiho
Mark W. El-Deiry, MD, FACS
Has no relevant financial relationships
Conor Steuer, MD
Consultant/Advisor/Speaker: Abbvie, Merck, Bergen Bio, Armo, Mirati, Caris, Sanofi/Regeron, Daiichi, Novocure
Edmund K. Waller, MD, PhD, FACP

Consultant: Novartis, Allogene, Biolimerx, Forte Biosciences, Sunuki

Stock: Cambium Oncology, Cambium Bio
David A. Frank, MD, PhD, FACP
Researcher: Roche-Genentech
Anthony M. Hunter, MD
Consultant/Advisor/Speaker: PharmaEssentia, Blueprint Medicines, Sobi/CTI biopharma, Novartis, Cogent Biosciences, GSK
Colin A. Vale, MD
Has no relevant financial relationships
Amelia A. Langston, MD

Consultant/Advisor/Speaker: Autolus

Researcher: BMS, Novartis, Kadmon, Incyte, Jazz Pharmaceuticals
Martha Arellano, MD
Has no relevant financial relationships
Hagop Kantarjian, MD
Has no relevant financial relationships
Melinda Yushak, MD, MPH
Grant/Research Support: Immunocore, BMS, GSK, Merck, Regeneron
Zachary S. Buchwald, MD, PhD
Has no relevant financial relationships
Michael Lowe, MD, MA
Consultant/Advisor/Speaker: BMS, Merck
Keith Delman, MD, FACS
Has no relevant financial relationships
Edjah K. Nduom, MD, FAANS
Advisory Board: Servier Pharmaceuticals, Kiyatec
Bree Eaton, MD
Has no relevant financial relationships
Bassel Nazha, MD, MPH

Consultant/Advisor/Speaker: Exelixis, IntrinsiQ Specialty Solutions-AmerisourceBergen, Cardinal Health, Intellisphere

Grants: Xencor, Merck, Astellas, Seagen
Jordan Ciuro, MD
Has no relevant financial relationships
Mehmet Bilen, MD
Consultant/Advisor/Speaker: Exelixis, Bayer, BMS, Eisai, Pfizer, AstraZeneca, Janssen, Calithera Biosciences, Genomic Health, Nektar, EMD Serono, SeaGen, and Sanofi

Grants: Merck, Xencor, Bayer, BristolMyers Squibb, Genentech/Roche, SeaGen, Incyte, Nektar, AstraZeneca, Tricon Pharmaceuticals, Exelixis, Nikang, Loxo Oncology, Ambrx, Regeneron, Acrivon Therapeutics, Amgen, Genome & Company, AAA, Peloton Therapeutics, and Pfizer
Michael Atkins, MD
Consultant/Advisor/Speaker: Abbvie, Agenus, AstraZeneca, Aveo, BMS, Eisai, Exelixis, Merck
Bradley Carthon, MD, PhD
Has no relevant financial relationships
Shreyas Joshi, MD, MPH
Consultant/Advisor/Speaker: CG Oncology, EnGene, Blue Earth Diagnostics, Photocure
Anant Mandawat, MD
Researcher: Pfizer, Myovent
James O. Armitage, MD

Consultant/Advisor/Speaker: Syncromune

Other: CRDF Oncology
Jason Romancik, MD

Consultant/Advisor/Speaker: ADC Therapeutics, AstraZeneca, KITE
Susan M. O’Brien, MD

Consultant: AbbVie, AstraZeneca, Autolus, Beigene, Ltd., BMS, Eli Lilly & Company, GSK, Janssen Oncology, J&J, Loxo Oncology, Inc., Merck, Pfizer, Pharmacyclics, TG Therapeutics, Vaniam Group LLC

Research Support: Alliance, AstraZeneca, Caribou Biosciences, Inc., Gilead, Kite, Mustang Bio, Nurix Therapeutics, Inc., Pfizer, Pharmacyclics, Regeneron, TG Therapeutics
Andres Chang, MD, PhD
Consultant/Advisor/Speaker: AstraZeneca
Jean Koff, MD

Consultant/Advisor/Speaker: AbbVie, BeiGene

Researcher: Viracta Therapeutics
Mary Jo Lechowicz, MD
Consultant/Advisor/Speaker: EUSA Pharma Board, Kyowa Kinn, Secura Bio, Inc.
Carlos A. Lopez, MD, MPH
Has no relevant financial relationships
Oluwadunni Emiloju, MBBS, MS
Individual publicly traded stocks and stock options: Telix Pharmaceuticals
Lindsay Hannan, MD, MSc
Has no relevant financial relationships
Daniel M. Halperin, MD

Researcher: Genentech, Themofisher Scientific, ITM, Novartis/AAA, Camurus, RayzeBio 

Consultant/Advisor/Speaker: Exelixis, Novartis, Crinetics, Harpoon Tx, ITM, Amryt, Camurus, Chimeric Tx

DSMB: Alphamedix
Olumide Gbolahan, MBBS, MSc
Has no relevant financial relationships
Maria C. Russell, MD
Has no relevant financial relationships
Jordan D. Berlin, MD

Advisory Boards: Mirati, Insmed, EMD Serono, Ipsen, Merck, Merus, BMS, Bexion, Mekanistic, Agenus, Astellas, Amplia

Research Support: AbbVie, Astellas, Atreca, Bayer, Dragonfly, I-Mab, Lilly, Incyte, EMD Serono, Pfizer, BMS, Tyra, Totus, Sumitomo Dainippon Pharma Oncology, 23 and me, parthenon/Incendia, hibercell, ribosciences, NCI

DSMB: AstraZeneca, Novocure, Boehringer-Ingelheim, I-SPY

Other: NCI
Olatunji Alese, MD
Consultant/Advisor/Speaker: Ipsen Pharmaceuticals, Aadi Biosciences, Taiho, Pfizer, Seagen, BMS, AstraZeneca, Exelixis
Charles Staley, MD
Has no relevant financial relationships
Beryl Manning-Geist, MD
Has no relevant financial relationships
Susan Modesitt, MD, FACOG, FACS
Has no relevant financial relationships
Jill Remick, MD
Has no relevant financial relationships
Sarah Dilley, MD, MPH, FACOG
Consultant/Advisor/Speaker: Intuitive
Ajay K. Nooka, MD, MPH, FACP
Consultant/Advisor/Speaker: Adaptive Biotech, Amgen, AZ, BMS, Cellectar biosciences, GSK, Janssen, K36 therapeutics, ONK therapeutics, Pfizer, Sanofi, Sebia and Takeda
Nisha Joseph, MD
Consultant/Advisor/Speaker: BMS, J&J Oncology, Takeda
Maddhav V. Dhodapkar, MBBS
Consultant/Advisor/Speaker: Sanofi, Janssen, Lava Therapeutics
Jonathan L. Kaufman, MD
Consultant/Advisor/Speaker: Sanofi, BMS, Sebia, AbbVie
Jennifer Carlisle, MD

Consultant/Advisor/Speaker: Amgen, catalyst

Researcher: Chipscreen Biosciences, Genentech, Inhibrix, Clinigen, Hutchmed
Sibo Tian, MD

Research Funding: Varian Medical Systems

Consultant/Advisor/Speaker: Merck, Genentech
Ticiana Leal, MD

Consultant/Advisor/Speaker: Janssen, OncoC4, Amgen, Gilead, Genentech, BMS, AbbVie, AstraZeneca, Novocure, Novartis, Takeda, Sanofi, Regeneron, Catalyst, Black Diamond

Other: Sanofi
Fatemeh Ardeshir, MD, MSc
Has no relevant financial relationships
Fadlo Khuri, MD
Has no relevant financial relationships
Jonathan Cohen, MD

Consultant/Advisor/Speaker: Kite/Gilead, Beigene, Janssen, Astra Zeneca, Lilly

Researcher: Astra Zeneca, Novartis, Takeda, Genentech, BMS/Celgene, Lilly
Pranav Santapuram, MD
Has no relevant financial relationships
Rahul Nayak
Has no relevant financial relationships
Taofeek K. Owonikoko, MD, PhD

Consultant/Advisor/Speaker: Novartis; Lilly; Eisai;  BristolMyers Squibb; Amgen; AstraZeneca; Boehringer

Ingelheim; EMD Serono; Bayer; Roche/Genentech, Inc.; Merck; Oncocyte; Takeda; Jazz Pharmaceuticals; Daiichi Sankyo; Janssen; BeiGene; Genentech; Coherus Biosciences;

GenCART; Heat Biologics; Meryx; Puma Biosciences; GSK, Gilead; Regeneron; Betta Pharmaceuticals; OncoHost;

Boehringer Ingelheim

Researcher: Amgen Inc.; AstraZeneca; Bayer Corporation;

Bristol Myers Squibb; Cardiff Oncology, Inc.; Eisai Inc.;

Roche/Genentech, Inc.; Merck & Co.,Inc.; Novartis Pharmaceuticals Corporation; Oncorus, Inc.; Pfizer; Turning

Point Therapeutics, Inc.; Y-mAbs Therapeutics, Inc;

Daiichi Sankyo; Puma Biosciences; Cyclacel; GSK; Boehringer

Ingelheim

Other: Coherus Biosciences; GenCART; Cambium Oncology, Taobob LLC
Kenneth C. Anderson, MD

Consultant/Advisor/Speaker: AstraZeneca, Janssen, Pfizer

Executive Role/Other: Dynamic Cell Therapies, C4 Therapeutics, NextRNA Therapeutics, Starton Therapeutics, Window Therapeutics

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact ddhoregistration@bioascend.com prior to the live event.

Fee Information

Registration fees are listed on the Register Now page.

Joint Accreditation Statement

Resim1

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Bio Ascend LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PACE designates this live activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 19 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Upon successfully completing the post-test with a passing score of 75% or better and activity evaluation, your certificate will be made available immediately. By selecting ABIM MOC credit, you are giving the providers permission to collect and submit the required individual learner completion data for the selected certifying boards via PARS.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

How To Claim Credit

To receive CE credit, learners must follow these steps:

  1. Visit https://paceducation.com/DDHO2024
  2. Complete the activity evaluation
  3. Upon completion of all evaluation questions, your credit will be made available for download immediately